Tirzepatide
-
Tirzepatide
structure -
-
CAS No:
2023788-19-2
-
Formula:
C225H348N48O68
-
Chemical Name:
Tirzepatide
-
Synonyms:
LY3298176;
- Categories:
-
CAS No:
Description
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Drug Information
Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist that integrates the actions of both incretins into a single novel molecule. GIP is a hormone that may complement the effects of GLP-1 receptor agonists. In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids. Tirzepatide is in phase 3 development for adults with obesity or overweight with weight-related comorbidity and is currently under regulatory review as a treatment for adults with type 2 diabetes. It is also being studied as a potential treatment for non-alcoholic steatohepatitis (NASH) and heart failure with preserved ejection fraction (HFpEF). Studies of tirzepatide in obstructive sleep apnea (OSA) and in morbidity/mortality in obesity are planned as well.
Tirzepatide Use and Manufacturing
The synthesis process of tirzepatide is as follows: to a reactor was charged dichloromethane (28.6 kg), water (5.4 kg), DTT (4.3 kg), Boc-Fragment 1 + 2 + 3 + 4 (14.3 kg, 8), and TIPS (3.3 kg), resulting in a slurry. The slurry was cooled to less than 10 °C before TFA (162 kg) was added over no more than 1.75 h, resulting in a solution. The solution was warmed to 21 °C and held at this temperature for 3 h. The solution was transferred to a separate reactor, rinsing with TFA (54.3 kg). This solution was cooled to ?10 °C and charged MTBE (125.8 kg) over 2 h. Then, additional MTBE (233 kg) was charged at 17 kg/h, maintaining an internal temperature of less than ?5 °C. The resulting slurry was warmed to 0 °C and then filtered. The wet cake was washed with MTBE (2 × 11 kg/kg relative to 8) and then dried under vacuum at no more than 35 °C to obtain tirzepatide (1, 8.71 kg, 1.81 mol, 81% yield)[1].
Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.
The synthesis process of tirzepatide is as follows: to a reactor was charged dichloromethane (28.6 kg), water (5.4 kg), DTT (4.3 kg), Boc-Fragment 1 + 2 + 3 + 4 (14.3 kg, 8), and TIPS (3.3 kg), resulting in a slurry. The slurry was cooled to less than 10 °C before TFA (162 kg) was added over no more than 1.75 h, resulting in a solution. The solution was warmed to 21 °C and held at this temperature for 3 h. The solution was transferred to a separate reactor, rinsing with TFA (54.3 kg). This solution was cooled to ?10 °C and charged MTBE (125.8 kg) over 2 h. Then, additional MTBE (233 kg) was charged at 17 kg/h, maintaining an internal temperature of less than ?5 °C. The resulting slurry was warmed to 0 °C and then filtered. The wet cake was washed with MTBE (2 × 11 kg/kg relative to 8) and then dried under vacuum at no more than 35 °C to obtain tirzepatide (1, 8.71 kg, 1.81 mol, 81% yield)[1].
Recommended Suppliers of Tirzepatide
-
![China]()
CN
2 YRS
Business licensedTrader Supplier of Tirzepatide,Retatrutide,SemaglutideInquiryUnit Price: $85-105 /UNIT FOBCAS No.: 2023788-19-2Grade: Pharmaceutical GradeContent: 99.9% -
![China]()
CN
1 YR
Business licensedTrader Supplier of Peptide,tirzepatide,retatrutide,semaglutideInquiryUnit Price: $95 /UNIT FOBCAS No.: 2023788-19-2Grade: Pharmaceutical GradeContent: 99% -
InquiryUnit Price: $140 /G FOBCAS No.: 2023788-19-2Grade: Pharmaceutical GradeContent: 99%
-
![China]()
CN
3 YRS
Business licensedTrader Supplier of Peptides,Tirzepatide,Semaglutide,Retatrutide,MT2,Adipotide,Tesamorelin,MOTS-c,5-amino-1mq,Botulinum toxinInquiryCAS No.: 2023788-19-2Grade: Pharmaceutical GradeContent: 99% -
![China]()
CN
6 YRS
Business licensedTrader Supplier of Sodium benzoate,Potassium sorbate,Xanthan gum,phosphoric acid,citric acidInquiryCAS No.: 2023788-19-2Grade: Pharmaceutical GradeContent: 99%
Latest News on Tirzepatide
- China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- Eli Lilly Tirzepatide's Phase III trial in obese or overweight adult patients in China was successful
- Eli Lilly's GIPR/GLP-1R Dual Agonist Tirzepatide Patent Layout
- Tirzepatide Enters the Field of Weight Loss and Will Achieve a 'Small Goal' of Over 10 Billion US Dollars.
- Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes in Two Phase 3 Trials from Lilly's SURPASS Program
Learn More Other Chemicals
-
2-Bromo-1-cyclopropylethanone
69267-75-0
-
VMCH
9005-09-8
-
Di(2-ethylhexyl) carbonate
14858-73-2
-
Pigment Red 123 Formula
24108-89-2
-
Bis((1H-Benzo[D][1,2,3]Triazol-1-Yl)Methyl)Amine Formula
111184-76-0
-
4,4′-Bis(2,3-epoxypropoxy)-3,3′,5,5′-tetramethylbiphenyl Formula
85954-11-6
-
Imidodisulfuryl fluoride, potassium salt (1:1) Structure
14984-76-0
-
5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester Structure
3543-74-6
-
What is 5-[Bis(2-hydroxyethyl)aMino]-1-(Methyl-d3)-1H-benziMidazole-2-butanoic Acid
1794737-33-9
-
What is 1,6-BIS(GUANIDINO)HEXANE SULFATE
6966-26-3